首页 > 最新文献

Surgical Laparoscopy, Endoscopy & Percutaneous Techniques最新文献

英文 中文
Mechanisms of Gastroesophageal Reflux Post-Roux-en-Y Gastric Bypass: Universal Alteration of the Antireflux Barrier is the Culprit. roux -en- y胃分流术后胃食管反流的机制:抗反流屏障的普遍改变是罪魁祸首。
IF 1.1 4区 医学 Q3 SURGERY Pub Date : 2025-04-09 DOI: 10.1097/SLE.0000000000001366
Barham K Abu Dayyeh, Karim Al Annan, Razan Aburumman, Tala Abedalqader, Rudy Mrad, Khushboo Gala, Vitor Brunaldi, Omar M Ghanem

Introduction: Gastroesophageal reflux disease (GERD) symptoms and the use of proton pump inhibitors (PPIs) remain prevalent after Roux-en-Y Gastric Bypass (RYGB), despite it being known to alleviate reflux. The physiological changes behind long-term GERD and hiatal hernia (HH) prevalence post-RYGB are not commonly investigated.

Methods: In this consecutive cohort study, we examined patients who underwent RYGB and subsequent upper endoscopy, conducted by an expert bariatric endoscopist. The primary focus was on pouch endoscopic retrosflexion to evaluate the antireflux barrier (ARB). We gathered data encompassing patient demographics, anthropometrics, comorbidities, and findings from esophagogastroduodenoscopy (EGD) at the time of surgery and during follow-up EGD.

Results: Our study included a total of 42 patients, predominantly female (97.5%) and White (100%), with an average age of 53.6±10.6 years and a body mass index (BMI) of 32.9±9.4 kg/m2. In our findings, all EGDs revealed the presence of a HH of varying sizes. The average HH size was 2.07±0.87 cm. The esophagogastric junction (EGJ) flap was also effaced in all patients with the majority (90.4%, 38 patients) classified as Hill grade IV and a smaller proportion (9.6%, 4 patients) as Hill grade III. Notably, PPI usage increased from the time of surgery to the time of EGD (69.0% vs. 42.9%, P=0.06).

Conclusion: This research highlights the high incidence of HH and EGJ flap effacement in patients after RYGB, potentially elucidating the persistence of reflux symptoms, including weakly acidic or alkaline reflux, post-RYGB.

导语:胃食管反流病(GERD)症状和质子泵抑制剂(PPIs)的使用在Roux-en-Y胃旁路术(RYGB)后仍然普遍存在,尽管已知它可以缓解反流。rygb后长期胃食管反流和裂孔疝(HH)患病率背后的生理变化尚未得到普遍调查。方法:在这项连续的队列研究中,我们检查了接受RYGB和随后由肥胖内窥镜专家进行的上消化道内窥镜检查的患者。主要的焦点是眼袋内窥镜后屈曲来评估抗反流屏障(ARB)。我们收集了包括患者人口统计学、人体测量学、合并症以及手术时和随访期间食管胃十二指肠镜检查(EGD)结果在内的数据。结果:本研究共纳入42例患者,以女性(97.5%)和白人(100%)为主,平均年龄53.6±10.6岁,体重指数(BMI) 32.9±9.4 kg/m2。在我们的研究中,所有EGDs都显示存在不同大小的HH。平均HH大小为2.07±0.87 cm。所有患者食管胃交界处(EGJ)皮瓣也均被抹去,大多数(90.4%,38例)为Hill IV级,较小比例(9.6%,4例)为Hill III级。值得注意的是,PPI的使用从手术时间到EGD时间有所增加(69.0%比42.9%,P=0.06)。结论:本研究强调了RYGB后HH和EGJ皮瓣消失的高发生率,可能阐明了RYGB后反流症状的持续存在,包括弱酸性或碱性反流。
{"title":"Mechanisms of Gastroesophageal Reflux Post-Roux-en-Y Gastric Bypass: Universal Alteration of the Antireflux Barrier is the Culprit.","authors":"Barham K Abu Dayyeh, Karim Al Annan, Razan Aburumman, Tala Abedalqader, Rudy Mrad, Khushboo Gala, Vitor Brunaldi, Omar M Ghanem","doi":"10.1097/SLE.0000000000001366","DOIUrl":"https://doi.org/10.1097/SLE.0000000000001366","url":null,"abstract":"<p><strong>Introduction: </strong>Gastroesophageal reflux disease (GERD) symptoms and the use of proton pump inhibitors (PPIs) remain prevalent after Roux-en-Y Gastric Bypass (RYGB), despite it being known to alleviate reflux. The physiological changes behind long-term GERD and hiatal hernia (HH) prevalence post-RYGB are not commonly investigated.</p><p><strong>Methods: </strong>In this consecutive cohort study, we examined patients who underwent RYGB and subsequent upper endoscopy, conducted by an expert bariatric endoscopist. The primary focus was on pouch endoscopic retrosflexion to evaluate the antireflux barrier (ARB). We gathered data encompassing patient demographics, anthropometrics, comorbidities, and findings from esophagogastroduodenoscopy (EGD) at the time of surgery and during follow-up EGD.</p><p><strong>Results: </strong>Our study included a total of 42 patients, predominantly female (97.5%) and White (100%), with an average age of 53.6±10.6 years and a body mass index (BMI) of 32.9±9.4 kg/m2. In our findings, all EGDs revealed the presence of a HH of varying sizes. The average HH size was 2.07±0.87 cm. The esophagogastric junction (EGJ) flap was also effaced in all patients with the majority (90.4%, 38 patients) classified as Hill grade IV and a smaller proportion (9.6%, 4 patients) as Hill grade III. Notably, PPI usage increased from the time of surgery to the time of EGD (69.0% vs. 42.9%, P=0.06).</p><p><strong>Conclusion: </strong>This research highlights the high incidence of HH and EGJ flap effacement in patients after RYGB, potentially elucidating the persistence of reflux symptoms, including weakly acidic or alkaline reflux, post-RYGB.</p>","PeriodicalId":22092,"journal":{"name":"Surgical Laparoscopy, Endoscopy & Percutaneous Techniques","volume":" ","pages":""},"PeriodicalIF":1.1,"publicationDate":"2025-04-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143812445","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Surgical Technique of Robotic Distal Gastrectomy for Gastric Cancer Using the Hinotori Surgical System. 应用Hinotori手术系统的机器人胃癌远端切除手术技术。
IF 1.1 4区 医学 Q3 SURGERY Pub Date : 2025-04-08 DOI: 10.1097/SLE.0000000000001369
Masaaki Nishi, Chie Takasu, Yuma Wada, Takuya Tokunaga, Hideya Kashihara, Daichi Ishikawa, Toshiaki Yoshimoto, Chiharu Nakasu, Mistuo Shimada

Aim: The da Vinci Surgical System (Intuitive Surgical) currently dominates robotic gastrectomy for gastric cancer. The hinotori Surgical Robot System (Medicaroid Corporation) is a newly developed, Japan-made surgical assist robot. This study aimed to introduce the initial experience of robotic gastrectomy using the hinotori and discuss key techniques and challenges.

Methods: This single-center retrospective study involved 10 eligible patients who underwent curative robotic distal gastrectomy using the hinotori for primary Stage I to III gastric cancer. Short-term surgical outcomes were evaluated. Lymph node dissection was mainly performed using the conventional double bipolar technique, left-handed double bipolar technique, or laparoscopic coagulation shears from the assist port.

Results: No patients developed intraoperative complications, and all procedures were successfully completed without conversion to open or laparoscopic surgery. All patients achieved R0 resection. The median operation time was 275 minutes (range, 252 to 336 min), and the estimated blood loss was 5 mL (range, 3 to 20 mL). The drain amylase content on postoperative day 1 was 220.5 IU/L (range, 66 to 1207 IU/L). The median number of retrieved lymph nodes was 29.5 (range, 11 to 58). No patients developed postoperative Clavien-Dindo grade ≥IIIa complications, and there was no mortality.

Conclusion: Robotic gastrectomy using the hinotori shows potential benefits for gastric cancer. Further studies are needed to validate these advantages.

目的:达芬奇手术系统(Intuitive Surgical)目前在机器人胃癌切除术中占主导地位。hinotori手术机器人系统(Medicaroid Corporation)是一款新开发的日本制造的手术辅助机器人。本研究旨在介绍利用hinotori进行机器人胃切除术的初步经验,并讨论关键技术和挑战。方法:这项单中心回顾性研究纳入了10例使用hinotori进行根治性机器人远端胃切除术的原发性I至III期胃癌患者。评估短期手术结果。淋巴结清扫主要使用传统的双极技术、左手双极技术或辅助口的腹腔镜凝血剪刀进行。结果:无患者出现术中并发症,所有手术均顺利完成,未转开腹或腹腔镜手术。所有患者均获得R0切除。中位手术时间为275分钟(范围252 ~ 336分钟),估计失血量为5ml(范围3 ~ 20ml)。术后第1天引流液淀粉酶含量为220.5 IU/L(范围66 ~ 1207 IU/L)。切除淋巴结中位数为29.5个(范围11 ~ 58个)。无患者发生术后Clavien-Dindo级≥IIIa级并发症,无死亡。结论:使用hinotori的机器人胃切除术对胃癌有潜在的疗效。需要进一步的研究来验证这些优势。
{"title":"Surgical Technique of Robotic Distal Gastrectomy for Gastric Cancer Using the Hinotori Surgical System.","authors":"Masaaki Nishi, Chie Takasu, Yuma Wada, Takuya Tokunaga, Hideya Kashihara, Daichi Ishikawa, Toshiaki Yoshimoto, Chiharu Nakasu, Mistuo Shimada","doi":"10.1097/SLE.0000000000001369","DOIUrl":"https://doi.org/10.1097/SLE.0000000000001369","url":null,"abstract":"<p><strong>Aim: </strong>The da Vinci Surgical System (Intuitive Surgical) currently dominates robotic gastrectomy for gastric cancer. The hinotori Surgical Robot System (Medicaroid Corporation) is a newly developed, Japan-made surgical assist robot. This study aimed to introduce the initial experience of robotic gastrectomy using the hinotori and discuss key techniques and challenges.</p><p><strong>Methods: </strong>This single-center retrospective study involved 10 eligible patients who underwent curative robotic distal gastrectomy using the hinotori for primary Stage I to III gastric cancer. Short-term surgical outcomes were evaluated. Lymph node dissection was mainly performed using the conventional double bipolar technique, left-handed double bipolar technique, or laparoscopic coagulation shears from the assist port.</p><p><strong>Results: </strong>No patients developed intraoperative complications, and all procedures were successfully completed without conversion to open or laparoscopic surgery. All patients achieved R0 resection. The median operation time was 275 minutes (range, 252 to 336 min), and the estimated blood loss was 5 mL (range, 3 to 20 mL). The drain amylase content on postoperative day 1 was 220.5 IU/L (range, 66 to 1207 IU/L). The median number of retrieved lymph nodes was 29.5 (range, 11 to 58). No patients developed postoperative Clavien-Dindo grade ≥IIIa complications, and there was no mortality.</p><p><strong>Conclusion: </strong>Robotic gastrectomy using the hinotori shows potential benefits for gastric cancer. Further studies are needed to validate these advantages.</p>","PeriodicalId":22092,"journal":{"name":"Surgical Laparoscopy, Endoscopy & Percutaneous Techniques","volume":" ","pages":""},"PeriodicalIF":1.1,"publicationDate":"2025-04-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143803532","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Extraperitoneal Colostomy Versus Transperitoneal Colostomy After Laparoscopic Abdominoperineal Resection for Rectal Cancer: A Systematic Review and Meta-analysis. 腹腔镜腹会阴直肠癌切除术后腹膜外结肠造口术与经腹膜结肠造口术:系统回顾和荟萃分析。
IF 1.1 4区 医学 Q3 SURGERY Pub Date : 2025-04-04 DOI: 10.1097/SLE.0000000000001365
Xin Jin, Yong Li, Bingchen Chen, Boan Zheng

Purpose: This study aimed to compare extraperitoneal colostomy (EPC) with transperitoneal colostomy (TPC) after laparoscopic abdominoperineal resection (APR) for rectal cancer regarding postoperative complications.

Method: A literature search was performed on PubMed, Ovid, and Cochrane Databases for studies comparing EPC with TPC after laparoscopic APR for rectal cancer. The last search was performed on June 4, 2024. The primary outcome was the incidence of parastomal hernia. The Review Manager (version 5.3) was used for data analysis.

Results: A total of 9 studies with 1002 patients were included in this meta-analysis. Among the enrolled literatures, one was randomized clinical trials, and others were retrospectively case-control designed. EPC showed significant efficiency in preventing parastomal hernia (P<0.001, OR=0.16, 95% CI: 0.09-0.28, I2=0%). Besides, the results indicated that the EPC group was associated with significantly less incidence of stoma retraction (P=0.02, OR=0.23, 95% CI: 0.06-0.81, I2=0%), stoma prolapse (P=0.002, OR=0.18, 95% CI: 0.06-0.54, I2=0%), and total stoma-related complications (P<0.001, OR=0.50, 95% CI: 0.33-0.74, I2=26%). In addition, no significant difference was observed between the 2 groups in terms of the total operative time or the time for colostomy creation.

Conclusion: Current data demonstrated the significant efficiency of EPC in preventing parastomal hernia after laparoscopic APR for rectal cancer. Besides, the clinical safety and feasibility of EPC were also indicated. The EPC procedure could be widely recommended for permanent colostomy in clinical practice.

目的:本研究旨在比较腹腔镜腹会阴切除术(APR)后直肠癌腹腔外结肠造口术(EPC)与经腹腔结肠造口术(TPC)的术后并发症。方法:检索PubMed、Ovid和Cochrane数据库,比较腹腔镜直肠癌APR术后EPC和TPC的研究。最后一次搜索是在2024年6月4日。主要结果是造口旁疝的发生率。Review Manager(5.3版本)用于数据分析。结果:本荟萃分析共纳入9项研究,共1002例患者。纳入的文献中,1篇为随机临床试验,其余为回顾性病例对照设计。结论:目前的数据表明,EPC在预防直肠癌腹腔镜APR术后造口旁疝方面有显著的效果。此外,还指出了EPC的临床安全性和可行性。EPC手术在临床上可广泛推荐用于永久性结肠造口。
{"title":"Extraperitoneal Colostomy Versus Transperitoneal Colostomy After Laparoscopic Abdominoperineal Resection for Rectal Cancer: A Systematic Review and Meta-analysis.","authors":"Xin Jin, Yong Li, Bingchen Chen, Boan Zheng","doi":"10.1097/SLE.0000000000001365","DOIUrl":"https://doi.org/10.1097/SLE.0000000000001365","url":null,"abstract":"<p><strong>Purpose: </strong>This study aimed to compare extraperitoneal colostomy (EPC) with transperitoneal colostomy (TPC) after laparoscopic abdominoperineal resection (APR) for rectal cancer regarding postoperative complications.</p><p><strong>Method: </strong>A literature search was performed on PubMed, Ovid, and Cochrane Databases for studies comparing EPC with TPC after laparoscopic APR for rectal cancer. The last search was performed on June 4, 2024. The primary outcome was the incidence of parastomal hernia. The Review Manager (version 5.3) was used for data analysis.</p><p><strong>Results: </strong>A total of 9 studies with 1002 patients were included in this meta-analysis. Among the enrolled literatures, one was randomized clinical trials, and others were retrospectively case-control designed. EPC showed significant efficiency in preventing parastomal hernia (P<0.001, OR=0.16, 95% CI: 0.09-0.28, I2=0%). Besides, the results indicated that the EPC group was associated with significantly less incidence of stoma retraction (P=0.02, OR=0.23, 95% CI: 0.06-0.81, I2=0%), stoma prolapse (P=0.002, OR=0.18, 95% CI: 0.06-0.54, I2=0%), and total stoma-related complications (P<0.001, OR=0.50, 95% CI: 0.33-0.74, I2=26%). In addition, no significant difference was observed between the 2 groups in terms of the total operative time or the time for colostomy creation.</p><p><strong>Conclusion: </strong>Current data demonstrated the significant efficiency of EPC in preventing parastomal hernia after laparoscopic APR for rectal cancer. Besides, the clinical safety and feasibility of EPC were also indicated. The EPC procedure could be widely recommended for permanent colostomy in clinical practice.</p>","PeriodicalId":22092,"journal":{"name":"Surgical Laparoscopy, Endoscopy & Percutaneous Techniques","volume":" ","pages":""},"PeriodicalIF":1.1,"publicationDate":"2025-04-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143781078","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Factors Affecting Liver Function Abnormalities After Laparoscopic Esophageal Hiatal Hernia Repair. 影响腹腔镜食管裂孔疝修补术后肝功能异常的因素。
IF 1.1 4区 医学 Q3 SURGERY Pub Date : 2025-04-01 DOI: 10.1097/SLE.0000000000001350
Jin Wu, Hao Feng, Zhen-Yuan Wang, Jie Li

Objective: In this study, we investigated the factors related to abnormal liver function in patients undergoing laparoscopic esophageal hiatal hernia repair.

Methods: The clinical data of 347 patients who underwent elective laparoscopic esophageal hiatal hernia repair at Beijing Chao-yang Hospital of Capital Medical University between January 2018 and November 2023 were retrospectively collected. The patients comprised 131 males and 216 females, ranging in age from 24 to 87 years, and were assessed using the ASA grading system between grades I and III. The patients were divided into 2 groups based on the presence or absence of liver function abnormalities on the first day after surgery: a normal liver function group (NLA group) and an abnormal liver function group (LA group). Patients with elevation in any of the following indicators were included in the LA group: alanine aminotransferase >40 U/L, glutamine aminotransferase >40 U/L, γ-glutamyltransferase >49 U/L, alkaline phosphatase >135 U/L, total bilirubin >17.1 μmol/L, or direct bilirubin >6.8 μmol/L. The clinical data of the 2 groups of patients were compared, and only the indicators with a P -value <0.15 were included in a binary logistic regression model analysis.

Results: There were 238 patients (68.6%) who developed liver function abnormalities on the first postoperative day. In comparison to the NLA group, the LA group had a significantly higher proportion of patients with esophageal hiatal hernia type II, type III, and type IV, hypotension, and high P ET CO 2 . Furthermore, the LA group had a significantly lower proportion of patients receiving blood transfusions. The maximum length and maximum cross-sectional area of the esophageal hiatal hernia were also significantly larger in the LA group. In addition, the operation time was significantly longer in the LA group. (all P -values are <0.15). The binary logistic regression analysis revealed that prolonged operation time (OR=1.017, 95% CI: 1.007-1.028) was the only risk factor associated with postoperative liver function abnormalities.

Conclusions: The sole risk factor for postoperative liver function abnormalities was prolonged surgical time.

目的:探讨腹腔镜食管裂孔疝修补术患者肝功能异常的相关因素。方法:回顾性收集2018年1月至2023年11月首都医科大学附属北京朝阳医院行选择性腹腔镜食管裂孔疝修补术的347例患者的临床资料。患者男性131例,女性216例,年龄24 ~ 87岁,采用ASA分级系统进行I ~ III级评估。根据术后第一天肝功能有无异常分为肝功能正常组(NLA组)和肝功能异常组(LA组)。以下任一指标升高的患者被纳入LA组:丙氨酸转氨酶>40 U/L,谷氨酰胺转氨酶>40 U/L, γ-谷氨酰转氨酶>49 U/L,碱性磷酸酶>135 U/L,总胆红素>17.1 μmol/L,或直接胆红素>6.8 μmol/L。比较两组患者的临床资料,仅取p值为a的指标结果:术后第一天出现肝功能异常238例(68.6%)。与NLA组相比,LA组出现II型、III型和IV型食管裂孔疝、低血压和高PETCO2的患者比例明显高于NLA组。此外,LA组接受输血的患者比例明显较低。LA组食管裂孔疝最大长度和最大横截面积也明显大于LA组。此外,LA组的手术时间明显更长。结论:手术时间延长是术后肝功能异常的唯一危险因素。
{"title":"Factors Affecting Liver Function Abnormalities After Laparoscopic Esophageal Hiatal Hernia Repair.","authors":"Jin Wu, Hao Feng, Zhen-Yuan Wang, Jie Li","doi":"10.1097/SLE.0000000000001350","DOIUrl":"10.1097/SLE.0000000000001350","url":null,"abstract":"<p><strong>Objective: </strong>In this study, we investigated the factors related to abnormal liver function in patients undergoing laparoscopic esophageal hiatal hernia repair.</p><p><strong>Methods: </strong>The clinical data of 347 patients who underwent elective laparoscopic esophageal hiatal hernia repair at Beijing Chao-yang Hospital of Capital Medical University between January 2018 and November 2023 were retrospectively collected. The patients comprised 131 males and 216 females, ranging in age from 24 to 87 years, and were assessed using the ASA grading system between grades I and III. The patients were divided into 2 groups based on the presence or absence of liver function abnormalities on the first day after surgery: a normal liver function group (NLA group) and an abnormal liver function group (LA group). Patients with elevation in any of the following indicators were included in the LA group: alanine aminotransferase >40 U/L, glutamine aminotransferase >40 U/L, γ-glutamyltransferase >49 U/L, alkaline phosphatase >135 U/L, total bilirubin >17.1 μmol/L, or direct bilirubin >6.8 μmol/L. The clinical data of the 2 groups of patients were compared, and only the indicators with a P -value <0.15 were included in a binary logistic regression model analysis.</p><p><strong>Results: </strong>There were 238 patients (68.6%) who developed liver function abnormalities on the first postoperative day. In comparison to the NLA group, the LA group had a significantly higher proportion of patients with esophageal hiatal hernia type II, type III, and type IV, hypotension, and high P ET CO 2 . Furthermore, the LA group had a significantly lower proportion of patients receiving blood transfusions. The maximum length and maximum cross-sectional area of the esophageal hiatal hernia were also significantly larger in the LA group. In addition, the operation time was significantly longer in the LA group. (all P -values are <0.15). The binary logistic regression analysis revealed that prolonged operation time (OR=1.017, 95% CI: 1.007-1.028) was the only risk factor associated with postoperative liver function abnormalities.</p><p><strong>Conclusions: </strong>The sole risk factor for postoperative liver function abnormalities was prolonged surgical time.</p>","PeriodicalId":22092,"journal":{"name":"Surgical Laparoscopy, Endoscopy & Percutaneous Techniques","volume":" ","pages":""},"PeriodicalIF":1.1,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142780575","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rectus Sheath and Transversus Abdominis Plane Blocks for Preaponeurotic Endoscopic Repair: Is the Double Block the Solution for Postoperative Pain Management?
IF 1.1 4区 医学 Q3 SURGERY Pub Date : 2025-04-01 DOI: 10.1097/SLE.0000000000001358
Antonio Toscano, Luca Domenico Bonomo, Paolo Capuano, Luca Cremascoli, Filippo Castelli, Mattia Puppo, Fabrizio Aprà, Alberto Jannaci, Salvatore Cuccomarino

Background: Diastasis recti abdominis (DRA) is a prevalent postpartum condition characterized by the separation of the rectus abdominis muscles with an interrectal distance >2.5 cm, often leading to symptoms like back pain, constipation, and urinary incontinence. Preaponeurotic endoscopic repair (REPA) is a novel, minimally invasive surgical approach for DRA, offering an alternative to traditional abdominoplasty. Despite its minimally invasive nature, REPA surgery poses significant postoperative pain challenges, typically managed with opioids, which carry numerous side effects.

Materials and methods: This retrospective study evaluates the efficacy of combining 2 ultrasound-guided abdominal wall blocks, rectus sheath block (RSB) and transversus abdominis plane block (TAPB), to manage postoperative pain in 55 DRA patients who underwent REPA surgery. We performed lateral TAPB in 28 cases, whereas 27 received an association of TAPB and RSB.

Results: At 6 hours postsurgery, 61% of patients in the TAPB group reported significant pain (Numeric Rating Scale >3), compared with 19% in the TAPB-RSB group ( P = 0.001). The TAPB-RSB group also required fewer analgesic rescue doses ( P = 0.042) and showed earlier recovery, with faster initiation of oral intake and mobility.

Conclusion: The combination of TAPB and RSB significantly reduces opioid consumption, postoperative pain, and the need for rescue analgesia compared with TAPB alone. The dual-block approach, providing a multi-dermatomal sensory block, suggests a promising strategy for improving postoperative pain management in REPA surgery.

{"title":"Rectus Sheath and Transversus Abdominis Plane Blocks for Preaponeurotic Endoscopic Repair: Is the Double Block the Solution for Postoperative Pain Management?","authors":"Antonio Toscano, Luca Domenico Bonomo, Paolo Capuano, Luca Cremascoli, Filippo Castelli, Mattia Puppo, Fabrizio Aprà, Alberto Jannaci, Salvatore Cuccomarino","doi":"10.1097/SLE.0000000000001358","DOIUrl":"10.1097/SLE.0000000000001358","url":null,"abstract":"<p><strong>Background: </strong>Diastasis recti abdominis (DRA) is a prevalent postpartum condition characterized by the separation of the rectus abdominis muscles with an interrectal distance >2.5 cm, often leading to symptoms like back pain, constipation, and urinary incontinence. Preaponeurotic endoscopic repair (REPA) is a novel, minimally invasive surgical approach for DRA, offering an alternative to traditional abdominoplasty. Despite its minimally invasive nature, REPA surgery poses significant postoperative pain challenges, typically managed with opioids, which carry numerous side effects.</p><p><strong>Materials and methods: </strong>This retrospective study evaluates the efficacy of combining 2 ultrasound-guided abdominal wall blocks, rectus sheath block (RSB) and transversus abdominis plane block (TAPB), to manage postoperative pain in 55 DRA patients who underwent REPA surgery. We performed lateral TAPB in 28 cases, whereas 27 received an association of TAPB and RSB.</p><p><strong>Results: </strong>At 6 hours postsurgery, 61% of patients in the TAPB group reported significant pain (Numeric Rating Scale >3), compared with 19% in the TAPB-RSB group ( P = 0.001). The TAPB-RSB group also required fewer analgesic rescue doses ( P = 0.042) and showed earlier recovery, with faster initiation of oral intake and mobility.</p><p><strong>Conclusion: </strong>The combination of TAPB and RSB significantly reduces opioid consumption, postoperative pain, and the need for rescue analgesia compared with TAPB alone. The dual-block approach, providing a multi-dermatomal sensory block, suggests a promising strategy for improving postoperative pain management in REPA surgery.</p>","PeriodicalId":22092,"journal":{"name":"Surgical Laparoscopy, Endoscopy & Percutaneous Techniques","volume":" ","pages":""},"PeriodicalIF":1.1,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143383317","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diagnosis and Treatment Options for Cirrhosis With Unexplained Upper Gastrointestinal Bleeding: An Observational Study Based on Endoscopic Ultrasonography. 肝硬化伴不明原因上消化道出血的诊断和治疗方案:基于内镜超声的观察性研究。
IF 1.1 4区 医学 Q3 SURGERY Pub Date : 2025-04-01 DOI: 10.1097/SLE.0000000000001355
Yuchuan Bai, Zhihong Wang, Chen Shi, Lihong Chen, Xuecan Mei, Derun Kong

Objective: To investigate the role of endoscopic ultrasonography (EUS) in the diagnosis and treatment of upper gastrointestinal bleeding of unknown origin in liver cirrhosis, focusing on patients with recurrent treatment of esophageal and gastric varices who failed to identify the bleeding site under direct endoscopy.

Background: Esophagogastric variceal bleeding is one of the severe complications of decompensated liver cirrhosis, and serial endoscopic therapy can improve the long-term quality of life of patients. Most acute bleeding can be detected under direct endoscopy with thrombus or active bleeding, but there are still some patients with recurrent bleeding after repeated treatments, and it is difficult to find the bleeding site, especially in gastric variceal bleeding. Therefore, it is of great significance to identify the bleeding site.

Patients and methods: A total of 88 patients with liver cirrhosis bleeding diagnosed and treated under EUS were collected in this study, including 26 patients who failed to identify the bleeding site under direct endoscopy. EUS was used to scan the bleeding site, and EUS-guided treatment was performed. The characteristics of the bleeding site under direct endoscopy and EUS and the follow-up results after surgery were analyzed.

Results: Among the 26 patients, 16 patients (16/26, 61.5%) showed red color signs of gastric fundus mucosa under direct endoscopy, 5 patients (5/26, 19.2%) showed punctate erosion, and the remaining 5 patients (5/26, 19.2%) showed no abnormal mucosal manifestations. All patients could find anechoic blood vessels under EUS, and blood flow signals could be detected within. Among them, 23 patients (23/26, 88.5%) chose EUS-guided treatment, and no rebleeding occurred after surgery. Another 3 patients (3/26, 11.5%) were given endoscopic variceal ligation due to small esophageal and gastric varices and inability to perform intravascular injection. The median follow-up time was 86 days. Adverse reactions included 5 cases of retrosternal pain (5/23, 21.7%), and 1 case of fever (1/23, 4.3%).

Conclusion: EUS can detect submucosal varices in the gastric mucosa, and these bleeding sites may present as red color signs or punctate erosion under direct endoscopy.

目的:探讨超声内镜(EUS)在肝硬化上消化道不明原因出血的诊断和治疗中的作用,重点关注食管和胃静脉曲张反复治疗,直接内镜下无法识别出血部位的患者。背景:食管胃静脉曲张出血是失代偿期肝硬化的严重并发症之一,连续内镜治疗可提高患者的长期生活质量。大多数急性出血伴血栓或活动性出血均可在内镜下直接检出,但仍有部分患者经多次治疗后出现复发性出血,出血部位难以发现,尤其是胃静脉曲张出血。因此,鉴别出血部位具有重要意义。患者和方法:本研究共收集88例经EUS诊断和治疗的肝硬化出血患者,其中26例在直接内镜下未发现出血部位。EUS扫描出血部位,EUS引导下进行治疗。分析直接内镜和EUS下出血部位的特点及术后随访结果。结果:26例患者中,16例(16/ 26,61.5%)患者在直接内镜下表现为胃底粘膜红色征象,5例(5/ 26,19.2%)患者表现为点状糜烂,其余5例(5/ 26,19.2%)患者未见粘膜异常表现。所有患者在EUS下均可发现无回声血管,血管内可检测到血流信号。其中23例(23/26,88.5%)患者选择eus引导治疗,术后无再出血。另有3例(3/26,11.5%)患者因食管和胃静脉曲张较小且无法进行血管内注射而行内镜下静脉曲张结扎术。中位随访时间为86天。不良反应包括胸骨后疼痛5例(5/23,21.7%),发热1例(1/23,4.3%)。结论:EUS可检出胃粘膜下静脉曲张,这些出血部位在直接内镜下可表现为红色征象或点状糜烂。
{"title":"Diagnosis and Treatment Options for Cirrhosis With Unexplained Upper Gastrointestinal Bleeding: An Observational Study Based on Endoscopic Ultrasonography.","authors":"Yuchuan Bai, Zhihong Wang, Chen Shi, Lihong Chen, Xuecan Mei, Derun Kong","doi":"10.1097/SLE.0000000000001355","DOIUrl":"10.1097/SLE.0000000000001355","url":null,"abstract":"<p><strong>Objective: </strong>To investigate the role of endoscopic ultrasonography (EUS) in the diagnosis and treatment of upper gastrointestinal bleeding of unknown origin in liver cirrhosis, focusing on patients with recurrent treatment of esophageal and gastric varices who failed to identify the bleeding site under direct endoscopy.</p><p><strong>Background: </strong>Esophagogastric variceal bleeding is one of the severe complications of decompensated liver cirrhosis, and serial endoscopic therapy can improve the long-term quality of life of patients. Most acute bleeding can be detected under direct endoscopy with thrombus or active bleeding, but there are still some patients with recurrent bleeding after repeated treatments, and it is difficult to find the bleeding site, especially in gastric variceal bleeding. Therefore, it is of great significance to identify the bleeding site.</p><p><strong>Patients and methods: </strong>A total of 88 patients with liver cirrhosis bleeding diagnosed and treated under EUS were collected in this study, including 26 patients who failed to identify the bleeding site under direct endoscopy. EUS was used to scan the bleeding site, and EUS-guided treatment was performed. The characteristics of the bleeding site under direct endoscopy and EUS and the follow-up results after surgery were analyzed.</p><p><strong>Results: </strong>Among the 26 patients, 16 patients (16/26, 61.5%) showed red color signs of gastric fundus mucosa under direct endoscopy, 5 patients (5/26, 19.2%) showed punctate erosion, and the remaining 5 patients (5/26, 19.2%) showed no abnormal mucosal manifestations. All patients could find anechoic blood vessels under EUS, and blood flow signals could be detected within. Among them, 23 patients (23/26, 88.5%) chose EUS-guided treatment, and no rebleeding occurred after surgery. Another 3 patients (3/26, 11.5%) were given endoscopic variceal ligation due to small esophageal and gastric varices and inability to perform intravascular injection. The median follow-up time was 86 days. Adverse reactions included 5 cases of retrosternal pain (5/23, 21.7%), and 1 case of fever (1/23, 4.3%).</p><p><strong>Conclusion: </strong>EUS can detect submucosal varices in the gastric mucosa, and these bleeding sites may present as red color signs or punctate erosion under direct endoscopy.</p>","PeriodicalId":22092,"journal":{"name":"Surgical Laparoscopy, Endoscopy & Percutaneous Techniques","volume":" ","pages":""},"PeriodicalIF":1.1,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142984874","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of Large Thyroid Nodules (≥4 cm) on Surgical Outcomes Following Endoscopic Thyroidectomy Through the Bilateral Axillo-Breast Approach. 大甲状腺结节(≥4cm)对经双侧腋窝-乳房入路内镜甲状腺切除术后手术效果的影响
IF 1.1 4区 医学 Q3 SURGERY Pub Date : 2025-04-01 DOI: 10.1097/SLE.0000000000001352
Lung-Yun Kang, Yu-Chia Chen, Tsung-Jung Liang

Objective: Endoscopic thyroidectomy through the bilateral axillo-breast approach (BABA) is predominantly used in cases involving low-risk thyroid malignancies and benign nodules measuring <4 cm. However, the efficacy and safety of this technique in larger goiters remain underexplored.

Methods: This retrospective study compared perioperative data and pathologic outcomes among patients who underwent endoscopic BABA thyroidectomy categorized on the basis of the size of the dominant nodule (<4 vs ≥4 cm).

Results: Among the 113 included patients, 81 (72%) had a dominant nodule measuring <4 cm (group 1) and 32 (28%) presented with a nodule measuring ≥4 cm (group 2). Group 2 experienced longer operative times, greater blood loss, and higher drainage volumes than group 1. However, pain scores and length of postoperative hospital stay were similar between the groups. None of the patients required conversion to open surgery. The incidence rates of vocal cord palsy and hypoparathyroidism did not differ significantly between groups. In group 2, three patients developed seroma (9%) and one exhibited delayed bleeding (3%). Pathologic examination revealed that 6 patients (19%) in group 2 had malignant neoplasms; 3 were identified in the dominant nodule, whereas the remaining 3 were identified in separate, smaller nodules. Throughout the mean follow-up period of 43 months, no recurrence or metastasis was reported.

Conclusions: Endoscopic BABA thyroidectomy is a viable option for patients with large thyroid nodules (≥4 cm); however, this technique requires careful execution.

目的双侧腋窝-乳房入路(BABA)内镜甲状腺切除术主要用于低风险甲状腺恶性肿瘤和良性结节的测量方法:这项回顾性研究比较了内镜下 BABA 甲状腺切除术患者的围手术期数据和病理结果,并根据主要结节的大小进行了分类(结果:在 113 例纳入研究的患者中,81 例(10%)接受了内镜下 BABA 甲状腺切除术(10%):在纳入的113例患者中,81例(72%)的主要结节大小为结论:对于甲状腺大结节(≥4厘米)患者来说,内镜下BABA甲状腺切除术是一种可行的选择;但是,这项技术需要谨慎实施。
{"title":"Impact of Large Thyroid Nodules (≥4 cm) on Surgical Outcomes Following Endoscopic Thyroidectomy Through the Bilateral Axillo-Breast Approach.","authors":"Lung-Yun Kang, Yu-Chia Chen, Tsung-Jung Liang","doi":"10.1097/SLE.0000000000001352","DOIUrl":"10.1097/SLE.0000000000001352","url":null,"abstract":"<p><strong>Objective: </strong>Endoscopic thyroidectomy through the bilateral axillo-breast approach (BABA) is predominantly used in cases involving low-risk thyroid malignancies and benign nodules measuring <4 cm. However, the efficacy and safety of this technique in larger goiters remain underexplored.</p><p><strong>Methods: </strong>This retrospective study compared perioperative data and pathologic outcomes among patients who underwent endoscopic BABA thyroidectomy categorized on the basis of the size of the dominant nodule (<4 vs ≥4 cm).</p><p><strong>Results: </strong>Among the 113 included patients, 81 (72%) had a dominant nodule measuring <4 cm (group 1) and 32 (28%) presented with a nodule measuring ≥4 cm (group 2). Group 2 experienced longer operative times, greater blood loss, and higher drainage volumes than group 1. However, pain scores and length of postoperative hospital stay were similar between the groups. None of the patients required conversion to open surgery. The incidence rates of vocal cord palsy and hypoparathyroidism did not differ significantly between groups. In group 2, three patients developed seroma (9%) and one exhibited delayed bleeding (3%). Pathologic examination revealed that 6 patients (19%) in group 2 had malignant neoplasms; 3 were identified in the dominant nodule, whereas the remaining 3 were identified in separate, smaller nodules. Throughout the mean follow-up period of 43 months, no recurrence or metastasis was reported.</p><p><strong>Conclusions: </strong>Endoscopic BABA thyroidectomy is a viable option for patients with large thyroid nodules (≥4 cm); however, this technique requires careful execution.</p>","PeriodicalId":22092,"journal":{"name":"Surgical Laparoscopy, Endoscopy & Percutaneous Techniques","volume":" ","pages":""},"PeriodicalIF":1.1,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143625998","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Choice of Anesthetic for Laparoscopic Bariatric Surgery Can Reduce the Use of Rescue Antiemetics in Postanesthesia Recovery Room: A Retrospective Observational Study. 腹腔镜减肥手术麻醉的选择可以减少麻醉后恢复室抢救止吐药的使用:一项回顾性观察研究。
IF 1.1 4区 医学 Q3 SURGERY Pub Date : 2025-04-01 DOI: 10.1097/SLE.0000000000001341
Juraj Sprung, David O Warner, Omar M Ghanem, Lauren Y Lu, Marita Salame, Darrell R Schroeder, Toby N Weingarten

Objective: Postoperative nausea and vomiting (PONV) is a frequent adverse event after bariatric surgery and is associated with patient dissatisfaction and increased health care burden. Aggressive multimodal antiemetic prophylaxis and the use of propofol infusion during anesthesia are associated with the reduction of PONV. In this study, we examined the use of rescue antiemetics following bariatric surgery performed with 3 different anesthetic strategies designed to reduce PONV: (1) primary volatile (VOL) anesthetic and propofol (PROP) infusion (VOL+PROP), (2) volatile anesthetic with propofol and dexmedetomidine (DEX) infusions (VOL+PROP+DEX), or (3) opioid-sparing total intravenous anesthesia (PROP+DEX).

Methods: In this retrospective observational study, we included patients undergoing bariatric surgery from 2018-2022 who received 1 of 3 anesthetics: (1) VOL+PROP, (2) VOL+PROP+DEX, or (3) opioid-sparing PROP+DEX without a VOL. Inverse probability of treatment weighting analysis determined the association between the need for rescue-antiemetics in the postanesthesia care unit (PACU) and following PACU discharge.

Results: Three hundred thirty-two patients received VOL+PROP, 354 VOL+PROP+DEX, and 166 PROP+DEX, and all received prophylactic antiemetics during surgery. After surgery, the PROP+DEX patients received fewer rescue antiemetics in the PACU compared with VOL+PROP (11% vs. 24%, P =0.002), and VOL+PROP+DEX fewer compared with VOL+PROP (16% vs. 24%, P =0.023). This differential antinausea effect was limited to PACU stay only. Rescue antiemetic use increased across all anesthetic management groups following PACU discharge until midnight on the day of surgery (ranging from 38% to 46% across groups, P =0.71) and through the first postoperative day (ranging from 47% to 57% across groups, P =0.20).

Conclusions: The benefit associated with anesthetic strategies designed to reduce PONV was present but did not persist past PACU discharge. This finding suggests that aggressive perioperative multimodal antiemetic prophylaxis combined with anesthetic strategies designed to prevent PONV after bariatric surgery have only a short-lived effect, thus health care staff in hospital wards may expect to encounter high rates of PONV in these patients. There is a need for the development of novel antinausea treatments to reduce the rate of this frequent postoperative complication.

目的:术后恶心和呕吐(PONV)是减肥手术后经常出现的不良反应,与患者的不满和医疗负担的增加有关。积极的多模式止吐预防和麻醉期间使用异丙酚输注与减少 PONV 有关。在这项研究中,我们考察了减肥手术后使用 3 种不同麻醉策略以减少 PONV 的情况:(1) 主要挥发性(VOL)麻醉剂和丙泊酚(PROP)输注(VOL+PROP);(2) 挥发性麻醉剂与丙泊酚和右美托咪定(DEX)输注(VOL+PROP+DEX);或 (3) 阿片类药物稀释全静脉麻醉(PROP+DEX):在这项回顾性观察研究中,我们纳入了 2018-2022 年期间接受减肥手术的患者,他们接受了 3 种麻醉药中的 1 种:(1)VOL+PROP;(2)VOL+PROP+DEX;或(3)不使用 VOL 的阿片类药物稀释型 PROP+DEX。治疗的逆概率加权分析确定了麻醉后护理病房(PACU)和 PACU 出院后抢救止吐药需求之间的关联:332 名患者接受了 VOL+PROP,354 名患者接受了 VOL+PROP+DEX,166 名患者接受了 PROP+DEX,所有患者在手术期间都接受了预防性止吐药。术后,与 VOL+PROP 相比,PROP+DEX 患者在 PACU 接受的抢救性止吐药更少(11% 对 24%,P=0.002),与 VOL+PROP 相比,VOL+PROP+DEX 患者接受的抢救性止吐药更少(16% 对 24%,P=0.023)。这种不同的止呕效果仅限于在 PACU 停留期间。所有麻醉管理组在 PACU 出院后到手术当天午夜(各组从 38% 到 46% 不等,P=0.71)以及术后第一天(各组从 47% 到 57% 不等,P=0.20)止吐药的使用量都有所增加:结论:旨在减少 PONV 的麻醉策略带来的益处是存在的,但在 PACU 出院后并未持续。这一发现表明,积极的围手术期多模式止吐预防措施与旨在预防减肥手术后PONV的麻醉策略相结合,只能产生短暂的效果,因此医院病房的医护人员可能会遇到这些患者PONV发生率较高的情况。因此,有必要开发新型抗恶心疗法,以降低这种术后常见并发症的发生率。
{"title":"Choice of Anesthetic for Laparoscopic Bariatric Surgery Can Reduce the Use of Rescue Antiemetics in Postanesthesia Recovery Room: A Retrospective Observational Study.","authors":"Juraj Sprung, David O Warner, Omar M Ghanem, Lauren Y Lu, Marita Salame, Darrell R Schroeder, Toby N Weingarten","doi":"10.1097/SLE.0000000000001341","DOIUrl":"10.1097/SLE.0000000000001341","url":null,"abstract":"<p><strong>Objective: </strong>Postoperative nausea and vomiting (PONV) is a frequent adverse event after bariatric surgery and is associated with patient dissatisfaction and increased health care burden. Aggressive multimodal antiemetic prophylaxis and the use of propofol infusion during anesthesia are associated with the reduction of PONV. In this study, we examined the use of rescue antiemetics following bariatric surgery performed with 3 different anesthetic strategies designed to reduce PONV: (1) primary volatile (VOL) anesthetic and propofol (PROP) infusion (VOL+PROP), (2) volatile anesthetic with propofol and dexmedetomidine (DEX) infusions (VOL+PROP+DEX), or (3) opioid-sparing total intravenous anesthesia (PROP+DEX).</p><p><strong>Methods: </strong>In this retrospective observational study, we included patients undergoing bariatric surgery from 2018-2022 who received 1 of 3 anesthetics: (1) VOL+PROP, (2) VOL+PROP+DEX, or (3) opioid-sparing PROP+DEX without a VOL. Inverse probability of treatment weighting analysis determined the association between the need for rescue-antiemetics in the postanesthesia care unit (PACU) and following PACU discharge.</p><p><strong>Results: </strong>Three hundred thirty-two patients received VOL+PROP, 354 VOL+PROP+DEX, and 166 PROP+DEX, and all received prophylactic antiemetics during surgery. After surgery, the PROP+DEX patients received fewer rescue antiemetics in the PACU compared with VOL+PROP (11% vs. 24%, P =0.002), and VOL+PROP+DEX fewer compared with VOL+PROP (16% vs. 24%, P =0.023). This differential antinausea effect was limited to PACU stay only. Rescue antiemetic use increased across all anesthetic management groups following PACU discharge until midnight on the day of surgery (ranging from 38% to 46% across groups, P =0.71) and through the first postoperative day (ranging from 47% to 57% across groups, P =0.20).</p><p><strong>Conclusions: </strong>The benefit associated with anesthetic strategies designed to reduce PONV was present but did not persist past PACU discharge. This finding suggests that aggressive perioperative multimodal antiemetic prophylaxis combined with anesthetic strategies designed to prevent PONV after bariatric surgery have only a short-lived effect, thus health care staff in hospital wards may expect to encounter high rates of PONV in these patients. There is a need for the development of novel antinausea treatments to reduce the rate of this frequent postoperative complication.</p>","PeriodicalId":22092,"journal":{"name":"Surgical Laparoscopy, Endoscopy & Percutaneous Techniques","volume":" ","pages":""},"PeriodicalIF":1.1,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143598055","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Factors Predicting Major Complications and Mortality in Percutaneous Endoscopic Gastrostomy: 8 Years of Experience of a Tertiary Surgery Center. 预测经皮内镜胃造瘘术主要并发症和死亡率的因素:一家三级外科中心 8 年的经验。
IF 1.1 4区 医学 Q3 SURGERY Pub Date : 2025-04-01 DOI: 10.1097/SLE.0000000000001342
Murat Yildirim, Asim Kocabay, Bulent Koca, Ali Ihsan Saglam, Namik Ozkan

Background: Percutaneous endoscopic gastrostomy (PEG) is a safe method of choice for patients who need long-term nutritional support. However, complications and high mortality rates have been reported. Based on 8 years of experience in tertiary care hospitals, we aimed to identify risk factors associated with major complications and 30-day mortality after PEG.

Methods: Patients who underwent PEG in the General Surgery clinic of Tokat Gaziosmanpaşa University, Faculty of Medicine between January 2014 and March 2022 were included in the study. Data regarding patient demographics, comorbidities, laboratory data, drugs used together, and indications for PEG tube placement were collected.

Results: There were 429 patients. The mean age of the patients was 66.9±16.75 years, and 180 (44%) patients were female. The mean follow-up period was 8.84±6.75 months. Twenty patients (4.9%) had major complications. Female sex [Odds Ratio (OR) 0.33, 95% CI, CI=1.23-8.87, P =0.02] and diabetes mellitus (DM) (OR=0.23, 95% CI=1.93-6, P =0.002) were the independent variables associated with major complications. The all-cause 30-day mortality rate was 5.9% (n=24). Malignancy, DM, corticosteroid use, low albumin, and platelet values were associated with increased mortality in multivariate analysis as indications for PEG.

Conclusions: Female sex and patients with DM may potentially face major complications. The patients with cancer, diabetes, and corticosteroid use were associated with higher mortality. In addition, low serum albumin and platelet levels were an effective factor for survival in patients undergoing PEG, and this should be taken into account in decision-making.

{"title":"Factors Predicting Major Complications and Mortality in Percutaneous Endoscopic Gastrostomy: 8 Years of Experience of a Tertiary Surgery Center.","authors":"Murat Yildirim, Asim Kocabay, Bulent Koca, Ali Ihsan Saglam, Namik Ozkan","doi":"10.1097/SLE.0000000000001342","DOIUrl":"10.1097/SLE.0000000000001342","url":null,"abstract":"<p><strong>Background: </strong>Percutaneous endoscopic gastrostomy (PEG) is a safe method of choice for patients who need long-term nutritional support. However, complications and high mortality rates have been reported. Based on 8 years of experience in tertiary care hospitals, we aimed to identify risk factors associated with major complications and 30-day mortality after PEG.</p><p><strong>Methods: </strong>Patients who underwent PEG in the General Surgery clinic of Tokat Gaziosmanpaşa University, Faculty of Medicine between January 2014 and March 2022 were included in the study. Data regarding patient demographics, comorbidities, laboratory data, drugs used together, and indications for PEG tube placement were collected.</p><p><strong>Results: </strong>There were 429 patients. The mean age of the patients was 66.9±16.75 years, and 180 (44%) patients were female. The mean follow-up period was 8.84±6.75 months. Twenty patients (4.9%) had major complications. Female sex [Odds Ratio (OR) 0.33, 95% CI, CI=1.23-8.87, P =0.02] and diabetes mellitus (DM) (OR=0.23, 95% CI=1.93-6, P =0.002) were the independent variables associated with major complications. The all-cause 30-day mortality rate was 5.9% (n=24). Malignancy, DM, corticosteroid use, low albumin, and platelet values were associated with increased mortality in multivariate analysis as indications for PEG.</p><p><strong>Conclusions: </strong>Female sex and patients with DM may potentially face major complications. The patients with cancer, diabetes, and corticosteroid use were associated with higher mortality. In addition, low serum albumin and platelet levels were an effective factor for survival in patients undergoing PEG, and this should be taken into account in decision-making.</p>","PeriodicalId":22092,"journal":{"name":"Surgical Laparoscopy, Endoscopy & Percutaneous Techniques","volume":" ","pages":""},"PeriodicalIF":1.1,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143190415","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Posterior Peroral Endoscopic Myotomy With Versus Without Sparing of the Oblique/Sling Fibers: A Meta-analysis. 后经口内窥镜下肌切开术与不保留斜/悬吊纤维:一项荟萃分析。
IF 1.1 4区 医学 Q3 SURGERY Pub Date : 2025-04-01 DOI: 10.1097/SLE.0000000000001353
Abdul-Rahman F Diab, Joseph A Sujka, Heena Patel, Saarangan Jegathesan, Alessandra Cruz Bou, Salvatore Docimo, Christopher G DuCoin

Background and aims: Several studies have hypothesized that sparing the oblique/sling fibers during posterior peroral endoscopic myotomy (POEM) may reduce the incidence of gastroesophageal reflux disease (GERD) and reflux esophagitis without compromising the established safety and efficacy of the procedure. This study compares perioperative, postoperative motility-related, and postoperative GERD-related outcomes between posterior oblique/sling fibers-sparing POEM (OFS-POEM) and conventional posterior POEM through a pairwise meta-analysis of comparative studies.

Methods: We conducted a systematic literature review following PRISMA guidelines to identify articles directly comparing posterior OFS-POEM with conventional posterior POEM. A pairwise meta-analysis was performed using a random-effects model. Effect sizes were calculated as odds ratios for dichotomous data and mean differences for continuous data.

Results: No significant differences were observed in perioperative outcomes, including mean gastric myotomy length, mean operative time, and incidence of adverse events. Similarly, no significant differences were noted in postoperative motility-related outcomes, such as mean Eckardt score and mean integrated relaxation pressure. However, a statistically significant reduction in the incidence of symptomatic GERD was observed in favor of OFS-POEM, with a number needed to treat (NNT) of 10 (95% CI: 6-49). Interestingly, no significant differences were found in the incidence of objectively diagnosed postoperative GERD, such as the number of patients with DeMeester scores >14 or the incidence of reflux esophagitis.

Conclusions: This study suggests that OFS-POEM may reduce the incidence of symptomatic GERD following POEM, without affecting the incidence of GERD diagnosed by pH studies (DeMeester score >14) or by endoscopy (reflux esophagitis). Future studies with larger sample sizes are needed to further investigate the impact of OFS-POEM on GERD incidence as determined by pH studies and endoscopic findings. Given the limitations of this study, no definitive conclusions can be drawn. Multicenter randomized controlled trials with larger sample sizes are required to reach more reliable conclusions. Furthermore, stratifying data according to the type and class of achalasia would provide valuable information on whether there are differences in outcomes among the various types and classes of achalasia.

背景和目的:一些研究假设,在经口后内镜下肌切开术(POEM)中保留斜/悬吊纤维可能会减少胃食管反流病(GERD)和反流性食管炎的发生率,而不会影响该手术的安全性和有效性。本研究通过对比较研究的两两荟萃分析,比较了后斜/悬吊纤维保留POEM (OFS-POEM)和传统后斜/悬吊纤维保留POEM的围手术期、术后运动相关和术后胃食管反流相关结果。方法:我们根据PRISMA指南进行了系统的文献综述,以确定直接比较后路OFS-POEM与传统后路POEM的文章。采用随机效应模型进行两两荟萃分析。效应量以二分数据的比值比和连续数据的平均差异计算。结果:围手术期预后无显著差异,包括平均胃肌切开术长度、平均手术时间和不良事件发生率。同样,术后运动相关结果,如平均Eckardt评分和平均综合放松压力,也没有显著差异。然而,OFS-POEM在症状性胃食管反流发生率上有统计学意义的显著降低,需要治疗的人数(NNT)为10 (95% CI: 6-49)。有趣的是,客观诊断的术后胃食管反流发生率(如DeMeester评分为> - 14的患者数量或反流性食管炎的发生率)无显著差异。结论:本研究提示OFS-POEM可降低POEM后症状性GERD的发生率,而不影响pH值检查(DeMeester评分>14)或内镜检查(反流性食管炎)诊断的GERD发生率。未来需要更大样本量的研究来进一步研究OFS-POEM对胃食管反流发生率的影响,这是由pH研究和内镜检查结果决定的。鉴于本研究的局限性,无法得出明确的结论。需要更大样本量的多中心随机对照试验才能得出更可靠的结论。此外,根据失弛缓症的类型和类别对数据进行分层将为不同类型和类别的失弛缓症的结局是否存在差异提供有价值的信息。
{"title":"Posterior Peroral Endoscopic Myotomy With Versus Without Sparing of the Oblique/Sling Fibers: A Meta-analysis.","authors":"Abdul-Rahman F Diab, Joseph A Sujka, Heena Patel, Saarangan Jegathesan, Alessandra Cruz Bou, Salvatore Docimo, Christopher G DuCoin","doi":"10.1097/SLE.0000000000001353","DOIUrl":"10.1097/SLE.0000000000001353","url":null,"abstract":"<p><strong>Background and aims: </strong>Several studies have hypothesized that sparing the oblique/sling fibers during posterior peroral endoscopic myotomy (POEM) may reduce the incidence of gastroesophageal reflux disease (GERD) and reflux esophagitis without compromising the established safety and efficacy of the procedure. This study compares perioperative, postoperative motility-related, and postoperative GERD-related outcomes between posterior oblique/sling fibers-sparing POEM (OFS-POEM) and conventional posterior POEM through a pairwise meta-analysis of comparative studies.</p><p><strong>Methods: </strong>We conducted a systematic literature review following PRISMA guidelines to identify articles directly comparing posterior OFS-POEM with conventional posterior POEM. A pairwise meta-analysis was performed using a random-effects model. Effect sizes were calculated as odds ratios for dichotomous data and mean differences for continuous data.</p><p><strong>Results: </strong>No significant differences were observed in perioperative outcomes, including mean gastric myotomy length, mean operative time, and incidence of adverse events. Similarly, no significant differences were noted in postoperative motility-related outcomes, such as mean Eckardt score and mean integrated relaxation pressure. However, a statistically significant reduction in the incidence of symptomatic GERD was observed in favor of OFS-POEM, with a number needed to treat (NNT) of 10 (95% CI: 6-49). Interestingly, no significant differences were found in the incidence of objectively diagnosed postoperative GERD, such as the number of patients with DeMeester scores >14 or the incidence of reflux esophagitis.</p><p><strong>Conclusions: </strong>This study suggests that OFS-POEM may reduce the incidence of symptomatic GERD following POEM, without affecting the incidence of GERD diagnosed by pH studies (DeMeester score >14) or by endoscopy (reflux esophagitis). Future studies with larger sample sizes are needed to further investigate the impact of OFS-POEM on GERD incidence as determined by pH studies and endoscopic findings. Given the limitations of this study, no definitive conclusions can be drawn. Multicenter randomized controlled trials with larger sample sizes are required to reach more reliable conclusions. Furthermore, stratifying data according to the type and class of achalasia would provide valuable information on whether there are differences in outcomes among the various types and classes of achalasia.</p>","PeriodicalId":22092,"journal":{"name":"Surgical Laparoscopy, Endoscopy & Percutaneous Techniques","volume":" ","pages":""},"PeriodicalIF":1.1,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142984875","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Surgical Laparoscopy, Endoscopy & Percutaneous Techniques
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1